Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.8 USD | +0.87% | +8.92% | +23.81% |
May. 02 | Pluri Inc. Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment | CI |
May. 02 | Pluri Inc. Announces Appointments to Its Scientific Advisory Board | CI |
Financials (USD)
Sales 2022 | 234K | Sales 2023 | 287K | Capitalization | 32.98M |
---|---|---|---|---|---|
Net income 2022 | -41M | Net income 2023 | -28M | EV / Sales 2022 | 58 x |
Net cash position 2022 | 26.21M | Net cash position 2023 | 10.27M | EV / Sales 2023 | 79.1 x |
P/E ratio 2022 |
-0.96
x | P/E ratio 2023 |
-1.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.12% |
1 day | +1.13% | ||
1 week | +8.92% | ||
Current month | +2.50% | ||
1 month | +2.50% | ||
3 months | -0.33% | ||
6 months | +26.16% | ||
Current year | +23.81% |
Managers | Title | Age | Since |
---|---|---|---|
Yaky Yanay
CEO | Chief Executive Officer | 52 | 06-10-31 |
Director of Finance/CFO | 40 | 13-04-30 | |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 21-07-14 | |
Lorne Abony
BRD | Director/Board Member | 55 | 23-07-10 |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 5.8 | +0.87% | 12 296 |
24-05-03 | 5.75 | +1.95% | 6,359 |
24-05-02 | 5.64 | +5.03% | 40,372 |
24-05-01 | 5.37 | -4.10% | 21,388 |
24-04-30 | 5.6 | +6.26% | 35,048 |
Delayed Quote Nasdaq, May 06, 2024 at 12:03 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+23.81% | 30.99M | |
+21.76% | 47.9B | |
+46.62% | 41.42B | |
-2.18% | 40.7B | |
-6.20% | 28.92B | |
+10.19% | 25.55B | |
-20.87% | 19.27B | |
-0.32% | 12.15B | |
+31.04% | 12.14B | |
-0.47% | 11.99B |
- Stock Market
- Equities
- PLUR Stock